NEW YORK – Thermo Fisher Scientific and Protein Metrics said on Monday that they are have signed a non-exclusive comarketing agreement for their respective mass spectrometry data processing and analysis platforms for biopharmaceutical and proteomics applications.
The agreement includes Thermo Fisher's cloud-enabled Thermo Scientific Chromeleon CDS software, which provides automation and workflow support in order to increase productivity. It also involves Protein Metrics' Byos platform for protein characterization, which allows scientists to monitor posttranslational modifications and other quality attributes, and the firm's private-cloud Byosphere enterprise platform for automation, collaboration, and data management.
"Our collaboration with Protein Metrics allows us to leverage our shared expertise and seamlessly integrate our compliance-ready software capabilities to offer customers flexible tools that address these challenges and help meet their need for advanced technologies that analyze their mass spectrometry data," said Matt Hazlewood, Thermo Fisher's senior director of global chromatography data systems, in a statement.
"Integrating [our platform] with critical enterprise data systems, such as Chromeleon CDS, we aim to provide our mutual biopharmaceutical customers with intuitive, streamlined workflows to manage the burgeoning volume and complexity of analytical data with confidence," said Eric Carlson, president and CEO of Protein Metrics.